IDEX Biometrics ASA
IDXAF
$0.002
$0.001100.00%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 333.33% | -58.62% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 333.33% | -58.62% | |||
| Cost of Revenue | -92.75% | 4,135.71% | |||
| Gross Profit | 101.55% | -3,973.33% | |||
| SG&A Expenses | -29.44% | -32.19% | |||
| Depreciation & Amortization | -90.19% | 478.23% | |||
| Other Operating Expenses | -30.73% | 87.20% | |||
| Total Operating Expenses | -45.82% | 44.53% | |||
| Operating Income | 47.36% | -46.00% | |||
| Income Before Tax | -7.81% | -382.50% | |||
| Income Tax Expenses | 101.64% | -- | |||
| Earnings from Continuing Operations | -11.40% | -373.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -11.40% | -373.53% | |||
| EBIT | 47.36% | -46.00% | |||
| EBITDA | 45.10% | -45.97% | |||
| EPS Basic | 28.57% | -262.79% | |||
| Normalized Basic EPS | 97.78% | -350.00% | |||
| EPS Diluted | 28.57% | -262.79% | |||
| Normalized Diluted EPS | 97.78% | -350.00% | |||
| Average Basic Shares Outstanding | 57.52% | 68.55% | |||
| Average Diluted Shares Outstanding | 57.37% | 68.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||